TrialsgrambetaRCTs are beautiful

CARP

2004

Coronary Artery Revascularization Prophylaxis trial

In 510 patients with stable coronary artery disease scheduled for elective major vascular surgery, prophylactic coronary revascularisation before surgery did not reduce long-term all-cause mortality or postoperative myocardial infarction compared with no preoperative revascularisation.

Result

Efficacy: Long-term all-cause mortality (median follow-up 2.7 years)relative risk 0.98 (95% CI 0.70-1.37) · P = 0.92

Below 1 favours prophylactic coronary revascularisation before surgery, above 1 favours no preoperative revascularisation.

Event rates
Absolute difference
1 points

The absolute difference is derived from the event rates.

Also reported: Postoperative MI within 30 days 12 % vs 14 % (p=0.37). Surgery was delayed by a median 54 vs 18 days.

Original publication
Subtopic
Preoperative revascularisation
Design
Open-label RCT
Relevance
Important: one of several pillars.
Source
McFalls EO, Ward HB, Moritz TE, et al. N Engl J Med. 2004;351(27):2795-2804.doi 10.1056/NEJMoa041905

Discussion & critique

Highly selected: only 9 % of screened patients were randomised, and left main disease and severe LV dysfunction were excluded, so it says nothing about the highest-risk anatomies. Within stable coronary disease it is definitive and is why routine prophylactic revascularisation before non-cardiac surgery is not recommended.

Discussed in podcasts